Applied Biosystems Unveils New Real-Time PCR Assays That Quantify Proteins in Human Cells

CARLSBAD, Calif.--(BUSINESS WIRE)--Applied Biosystems, part of Life Technologies Corporation (NASDAQ:LIFE), today announced the introduction of a new line of TaqMan® real-time PCR assays that enable researchers to rapidly detect and quantify proteins in human cell samples. The TaqMan Protein Expression Assays enable researchers to correlate relative levels of specific proteins with cell functions and behaviors, such as different disease conditions, or states of pluripotency or differentiation in stem cells. The initial release of these molecular tools includes assays that enable relative quantification of protein markers for pluripotency from limited quantities of cultured human embryonic stem cells.